Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 24Pancreatic Neoplasms 14Stomach Neoplasms 12Rectal Neoplasms 12Squamous Cell Carcinoma of Head and Neck 9Esophageal Neoplasms 9Colonic Neoplasms 9Neoplasms 7Adenocarcinoma Of Esophagus 7Urinary Bladder Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Neoplasm Metastasis 4Head and Neck Neoplasms 4Esophageal Squamous Cell Carcinoma 4Cholangiocarcinoma 4Breast Neoplasms 4Anus Neoplasms 4Ovarian Neoplasms 3Nasopharyngeal Carcinoma 2Melanoma 2Hepatoblastoma 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Clinical Stage I Gastric Cancer AJCC v8 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Urethral Neoplasms 1Urachal cancer 1Unresectable Colorectal Cancer 1

Interventions

Nivolumab 2Immunoglobulin G 2Disulfides 2Bevacizumab 2atezolizumab 1Taxes 1Specimen Handling 1Paclitaxel 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Leucovorin 1Ipilimumab 1Gemcitabine 1Fluorouracil 1Docetaxel 1Carboplatin 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Adenocarcinoma, Mucinous × Fluorouracil × Clear all
NCT05504252 2026-01-07

METIMMOX-2

University Hospital, Akershus

Phase 2 Active not recruiting
80 enrolled

Adenocarcinoma, Mucinous, Carcinoma, Signet Ring Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡